39827-11-7 Usage
Uses
Used in Organic Synthesis:
Benzo[b]thiophene-2-carbonyl chloride is used as a reagent for the introduction of the benzo[b]thiophene-2-carbonyl moiety into target molecules. This allows for the creation of a wide range of organic compounds with diverse properties and applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, benzo[b]thiophene-2-carbonyl chloride is used for the development of new compounds with potential biological activities. Its unique structure and reactivity make it a valuable building block in the synthesis of pharmaceutical agents.
Used in Agrochemical Industry:
Benzo[b]thiophene-2-carbonyl chloride is also utilized in the agrochemical industry for the development of new compounds with potential applications in agriculture, such as pesticides or herbicides.
Used in Academic Research:
Benzo[b]thiophene-2-carbonyl chloride is important for academic research in the study of heterocyclic compounds and their reactivity. Researchers use benzo[b]thiophene-2-carbonyl chloride to explore the chemical properties and reactions of heterocyclic systems, contributing to the understanding of these complex molecules and their potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 39827-11-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,8,2 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 39827-11:
(7*3)+(6*9)+(5*8)+(4*2)+(3*7)+(2*1)+(1*1)=147
147 % 10 = 7
So 39827-11-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H5ClOS/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5H
39827-11-7Relevant academic research and scientific papers
Diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
-
, (2008/06/13)
A compound of the formula: STR1 wherein R1 --A-- is a group of the formula: STR2 in which R1 is aryl or a heterocyclic group, each of which may be substituted with substituent(s) selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, halo(lower)alkyl, acyl, acylamino and halogen, or lower alkyl which may be substituted with a heterocyclic group optionally substituted with acyl, and X is O or S, and R2 is hydrogen or lower alkyl, provided that when R1 is lower alkyl, then R1 --A-- is a group of the formula: STR3 in which R1 and X are each as defined above, and pharmaceutically acceptable salts thereof, processes for the preparation thereof and pharmaceutical composition comprising the same.
